RT Journal Article
SR Electronic
T1 Gemfibrozil reduced the risk for coronary events in men with coronary artery disease and low levels of high density lipoprotein cholesterol
JF Evidence Based Medicine
JO Evid Based Med
FD BMJ Publishing Group Ltd
SP 49
OP 49
DO 10.1136/ebm.5.2.49
VO 5
IS 2
YR 2000
UL http://ebm.bmj.com/content/5/2/49.abstract
AB